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In beginning this overview, I want to acknowledge
the fact that, even though I disagree with most of his
conclusions, Bruce Ames has played an important role
in further stimulating interest in cell proliferation in
carcinogenesis. This meeting has provided a balanced
discussion of the current state of knowledge in this
field. It has also highlighted the complexities of cell
proliferation, the need for further mechanistic studies,
and the desirability of developing new methods that
can be used to precisely quantitate the various parame-
ters related to cell proliferation in the intact organism.
At this meeting and in a recent paper (1), Ames has
put forth several postulates that I believe represent
an oversimplification of the multistage carcinogenic
process. These postulates include the following: a) the
aging process per se is a major factor in human cancer
causation; b) oxidative damage due to endogenous fac-
tors plays a major role in human cancer causation; c)
mitogenesis (induced cell division) plays a major role in
carcinogenesis by increasing mutagenesis; d) the stan-
dard National Toxicology Program (NTP) rodent
bioassay frequently yields unreliable results with
respect to predicting human carcinogens; and e) syn-
thetic pesticides and certain other synthetic chemicals
pose lesser carcinogenic risks than nature's pesticides
and other naturally occurring chemicals in various food
stuffs. Elsewhere, I have reviewed evidence that calls
into question these conclusions (2,3). Some of this evi-
dence was discussed at this meeting and will be briefly
reviewed here. Some ofAmes' postulates may apply in
specific cases. I do not believe, however, that there is
sufficient evidence at the present time to use these
postulates as a general basis for discarding current
methods ofcarcinogen detection and risk extrapolation
or for altering current guidelines for regulating poten-
tial carcinogens.
With respect to Ames' criticism ofthe standard NTP
rodent carcinogen bioassay, we have heard evidence
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from several speakers that in most cases the positive
results obtained in this bioassay cannot be attributed
to nonspecific toxicity or excessive cell proliferation as
a consequence of high doses of the test agent (3).
Furthermore, various experimental studies indicate
that there is no simple correlation between cell prolif-
eration or hyperplasia and carcinogenicity. At the
same time, cell proliferation is obviously necessary for
mutagenesis and tumorigenesis, and in some situations
it may be one ofthe rate-limiting events. I doubt, how-
ever, that sustained cell proliferation is in itself suffi-
cient to drive the carcinogenic process. We have heard
examples in which high doses of an agent might pro-
duce a type of cellular toxicity that does not occur at
low doses, for example, the production of crystalluria
in the bladder by saccharine or the precipitation ofa2U-
globulin in the kidney by certain organic solvents.
These examples are instructive, but they do not invali-
date all of the rodent bioassays. Indeed, it should be
emphasized that rodent bioassays have predicted sev-
eral known human carcinogens, and we should not
ignore the evidence that chemical carcinogens play an
important role in the causation ofhuman cancer. Thus,
chemicals in cigarette smoke cause about one-third of
all the cancers in the United States, and over 50 specif-
ic chemicals or industrial processes are known to be
carcinogenic in humans. It appears that dietary factors
also play a major role, but the precise chemicals in our
diet that are involved and the mechanisms by which
they act are, in general, not known.
During this meeting, several investigators discussed
evidence that the birth, growth, and death of cells are
complex phenomena. It is not sufficient, therefore, to
speak only ofcell proliferation or mitogenesis. De novo
cell replication can be induced by various agonists,
both endogenous and exogenous. Carcinogenicity is
not simply a regenerative response to cell toxicity.
Furthermore, the fate of newly synthesized cells is a
function ofnumerous subsequent events, which include
further exponential division, terminal differentiation,
programmed cell death (apoptosis), and tissue necrosis.
There is no assurance, therefore, that mitogenic stim-
uli will lead to mutation and clonal expansion. We need
much more information on the possible effects of and
mechanisms by which various xenobiotic chemicals1L B. WEINSTEIN
influence cell cycling (see below), cell replication, dif-
ferentiation, and apoptosis.
It seems likely that certain xenobiotics might pro-
duce their carcinogenic effects by disturbing specific
steps in signal transduction pathways and the control
of gene expression, thereby enhancing cell prolifera-
tion and clonal expansion. Thus, the potent tumor-pro-
moting role of the phorbol esters and certain related
compounds is due to their ability to bind to and acti-
vate protein kinase C (PKC), an enzyme that plays a
key role in signal transduction (2,4). It will be of
interest, therefore, to determine whether other non-
genotoxic carcinogens (i.e., agents that do not directly
damage DNA) might exert their effects through
growth-factor receptors, phospholipases, G proteins,
specific protein kinases, or transcription factors.
Insights into these mechanisms would provide a more
scientific basis for risk extrapolation between species
and tissues and from high doses to low doses.
I want to emphasize that it appears that genotoxic
agents, by inducing complex cellular responses to DNA
damage, can also perturb cellular pathways of signal
transduction and gene expression (2). Thus, the effects
ofgenotoxic agents on cell proliferation may not simply
reflect nonspecific toxicity that occurs only at high
doses of the agent. The phenomenon of inducible
responses to DNA damage complicates risk extrapola-
tion. The dose-response curve forthe mutagenic effects
of a given genotoxic agent may not be the same as the
dose-response curve for the inducible effects produced
by the same agent. The dose-response curve for car-
cinogenicity might, therefore, be a complex function of
both types ofeffects. This curve could in turn be a func-
tion ofnumerous other variables (i.e., the target tissue,
the species and age ofthe host, and parallel exposure to
other agents). The mutational spectra in the p53 gene
discussed at this meeting provide an exciting example
ofhow mutations in the DNA oftumor cells might pro-
vide a fingerprint ofthe original causative agent and/or
the original mutagenic event(s) involved in carcinogen-
esis. It will be of interest, therefore, to examine the
mutational spectra ofaltered genes in tumors produced
by nongenotoxic agents or by putative endogenous fac-
tors such as hormones or reactive forms of oxygen.
These mutational spectra, when compared to those pro-
duced by known genotoxic agents, may provide clues to
the underlying mechanisms.
At this meeting, several investigators discussed
recent exciting findings on the factors that control the
cell cycle and of check points that monitor the fidelity
ofeach phase ofthe cell cycle. It seems likely that cer-
tain xenobiotic agents might enhance the carcinogenic
process by affecting specific cyclins, the cdk protein
kinases activated by these cyclins, or various protein
kinases and protein phosphatases that also regulate
these events. Furthermore, mutations in the related
genes during the course of multistage carcinogenesis
could abrogate normal check-point control mechanisms
or influence the fidelity ofDNA and chromosome repli-
cation, thus contributing to genomic instability. In this
regard, it was ofinterest to learn that mutations in the
p53 gene appear to abrogate a check-point related to
DNA damage. Our laboratory recently found that a
cyclin D gene, Prad 1, is amplified and overexpressed
in about 25% of human esophageal cancers (5).
Abnormalities in this gene have also been seen in other
types ofhuman tumors (5,6). Thus the cyclin-cdk kinase
system may represent an important set of cellular tar-
gets in multistage carcinogenesis.
Several speakers discussed interesting theoretical
models of multistage carcinogenesis. My own view is
that such models are highly useful in the design ofnew
experiments. Since, however, each of these models
makes several important assumptions, I believe that at
the present time none of these models can be used to
do quantitative risk assessment with confidence or
precision. A major challenge for future research is to
develop experimental methods for identifying and
quantitating each of the individual steps in the multi-
stage process so that risk assessment calculations can
be done with greater confidence.
In conclusion, I want to list what I think are certain
key questions and new frontiers in the field ofenviron-
mental carcinogenesis. The first is that we need much
more basic research on the cellular and molecular
mechanisms that control cell proliferation, the cell
cycle, and cell death. Closely related to these subjects
is the need to expand our knowledge on mechanisms of
signal transduction and the control ofgene expression.
Second, I would encourage intensive research on the
possibility that certain xenobiotics exert their carcino-
genic or other toxic effects on cells not by damaging
DNA but by targeting specific cellular molecules
involved in signal transduction, gene expression, and
cell cycle control. Third, we need to develop convenient
biomarkers that can be used to score for perturbations
in the latter events, in cells in culture and in rodents
that are exposed to putative carcinogens. It is hoped
that some of these biomarkers can be used in humans
as an extension of current molecular epidemiology
studies because at the present time these studies are
restricted mainly to studying genotoxic-type events.
Fourth, we need to expand our research into the roles
ofdietary and hormonal factors in human cancer causa-
tion. It is possible that these factors act through both
genotoxic and nongenotoxic mechanisms. In recent
studies (4), we have obtained evidence that a high-fat
diet might enhance colon carcinogenesis by leading to
the formation in the lumen of the colon diacyglycerol,
an activator ofPKC. Other mechanisms should also be
investigated, using both experimental models and
human studies. Finally, the emerging interest in inter-
vention approaches, including dietary modifications
and chemoprevention, holds great promise in terms of
cancer prevention (4). These approaches should also
help validate (or invalidate) some of the predictions
made from experimental and epidemiologic studies,
thus improving the science ofrisk assessment.
160CELL PROLIFERATION: CONCLUDING REMARKS 161
On behalfofall the conference participants, I want to
thank the organizers and sponsors for providing an
informative and stimulating conference on a fundamen-
tal area ofbiology that is highly relevant to the field of
environmental health science. I am certain that the
discussions we have had will catalyze advances in this
important field ofpublic health.
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